Back

Efficacy of in-hosptal initiation of dapagliflozin in prevention of heart failure in non-diabetic patients with anterior wall ST-segment elevation acute myocardial infarction

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - prevention Prevention HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Mr Levon Hayrapetyan

Yerevan State Medical University after M. Heratsi, Yerevan (Armenia)

6 More presentations in this session

Presentation thumbnail
Implementation of a heart failure management programme (HF-MP) to improve patient access to services throughout their heart failure journey: a service improvement evaluation.
Mr R. Williams (Bridgend, GB)
Abstract Slides Video
Presentation thumbnail
Transcatheter aortic valve implantation initial experience in high risk patients with heart failure
Professor H. Sisakian (Yerevan, AM)
Abstract Slides Video
Presentation thumbnail
Mathematical model for estimating readmissions during the vulnerable period of patients with heart failure
Assistant Professor A. Lacraru (Bucharest, RO)
Abstract Slides Video
Presentation thumbnail
The AST to ALT ratio: a new predictor for left ventricular systolic dysfunction following ST segment myocardial infarction
Assistant Professor V. Halatiu (Targu Mures, RO)
Abstract Slides Video
Presentation thumbnail
Adverse events in patients admitted in an outpatient heart failure medical unit: an observational study
Doctor S. Costa Monteiro (Aveiro, PT)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in chronic heart failure - prevention

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Efficacy and safety of dapagliflozin in non-diabetic patients with primary anterior ST-elevation myocardial infarction initiated in early hospital period
thumbnail
Congress Presentation
Potential cardio-protective role of dapagliflozin in diabetic patients presented with anterior ST-elevation myocardial infarction (STEMI).
thumbnail
Congress Presentation
Beyond heart failure: impact of sodium-glucose co-transporter-2 inhibitors after acute coronary syndrome

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources